Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Abramovitch, R, Marikovsky, M, Meir, G & Neeman, M (1999). Stimulation of tumour growth by wound-derived growth factors. Br J Cancer 79: 1392–1398.
Coley, WB (1911). Injury as a causative factor in cancer. Ann Surg 4: 449–482.
Elwood, M, McNoe, B, Smith, T, Bandaranayake, M & Doyle, TCA (1998). Once is enough: why some women do not continue to participate in a breast cancer screening programme. N Z Med J 111: 180–183.
Poulos, A & Rickard, M (1997). Compression mammography and the perception of discomfort. Australas Radiol 41: 247–252.
Thornton, H & Baum, M (1999). Should a mammographic screening programme carry the warning: screening can damage your health?. Br J Cancer 79: 691–692.
Sjonell, G & Stahle, L (1999). Mammographic screening does not reduce breast cancer mortality. Lakartidningen 96: 904–905, 908–913.
van Netten, JP, Mogentale, T, Ashwood-Smith, MJ, Fletcher, C & Coy, P (1994). Physical trauma and breast cancer. Lancet 343: 978–979.
van Netten, JP, Cann, SA & Hall, JG (1997). Mammography controversies: time for informed consent?. J Natl Cancer Inst 89: 1164–1165.
Abramovitch, R, Marikovsky, M, Meir, G & Neeman, M (1999). Stimulation of tumour growth by wound-derived growth factors. Br J Cancer 79: 1392–1398.
Coley, WB (1911). Injury as a causative factor in cancer. Ann Surg 4: 449–482.
Elwood, M, McNoe, B, Smith, T, Bandaranayake, M & Doyle, TCA (1998). Once is enough: why some women do not continue to participate in a breast cancer screening programme. N Z Med J 111: 180–183.
Poulos, A & Rickard, M (1997). Compression mammography and the perception of discomfort. Australas Radiol 41: 247–252.
Thornton, H & Baum, M (1999). Should a mammographic screening programme carry the warning: screening can damage your health?. Br J Cancer 79: 691–692.
Sjonell, G & Stahle, L (1999). Mammographic screening does not reduce breast cancer mortality. Lakartidningen 96: 904–905, 908–913.
van Netten, JP, Mogentale, T, Ashwood-Smith, MJ, Fletcher, C & Coy, P (1994). Physical trauma and breast cancer. Lancet 343: 978–979.
van Netten, JP, Cann, SA & Hall, JG (1997). Mammography controversies: time for informed consent?. J Natl Cancer Inst 89: 1164–1165.
Andersson, C, Iresjo, BM & Lundholm, K (1991). Identification of tissue sites for increased albumin degradation in sarcoma-bearing mice. J Surg Res 50: 156–162.
Bohley, P & Seglen, PO (1992). Proteases and proteolysis in the lysosome. Experientia 48: 151–157.
Briozzo, P, Morisset, M, Capony, F, Rougeot, C & Rochefort, H (1988). In vitro degradation of extracellular matrix with Mr 52 000 cathepsin D secreted by breast cancer cells. Cancer Res 48: 3688–3692.
Chen, WT (1996). Proteases associated with invadopodia, and their role in degradation of extracellular matrix. Enzyme Protein 49: 59–71.
Collins, MK & Lopez Rivas, A (1993). The control of apoptosis in mammalian cells. Trends Biochem Sci 18: 307–309.
Coopman, PJ, Do, MT, Thompson, EW & Mueller, SC (1998). Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity. Clin Cancer Res 4: 507–515.
Duffy, MJ & McCarthy, K (1998). Matrix metalloproteinases in cancer: prognostic markers and targets for therapy (review). Int J Oncol 12: 1343–1348.
Foekens, JA, Look, MP, Bolt-de Vries, J, Meijer-van Gelder, ME, van Putten, WLJ & Klijn, JGM (1999). Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients. Br J Cancer 79: 300–307.
Johnson, MD, Torri, JA, Lippman, ME & Dickson, RB (1993). The role of cathepsin D in the invasiveness of human breast cancer cells. Cancer Res 53: 873–877.
Kelly, T, Mueller, SC, Yeh, Y & Chen, WT (1994). Invadopodia promote proteolysis of a wide variety of extracellular matrix proteins. J Cell Physiol 158: 299–308.
Lipponen, P, Aaltomaa, S, Kosma, VM & Syrjanen, K (1994). Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer 30: 2068–2073.
Mego, JL (1984). Role of thiols, pH and cathepsin D in the lysosomal catabolism of serum albumin. Biochem J 218: 775–783.
Montcourrier, P, Mangeat, PH, Salazar, G, Morisset, M, Sahuquet, A & Rochefort, H (1990). Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles. Cancer Res 50: 6045–6054.
Montcourrier, P, Mangeat, PH, Valembois, C, Salazar, G, Sahuquet, A, Duperray, C & Rochefort, H (1994). Characterization of very acidic phagosomes in breast cancer cells and their association with invasion. J Cell Sci 107: 2381–2391.
Nakahara, H, Howard, L, Thompson, EW, Sato, H, Seiki, M, Yeh, Y & Chen, WT (1997). Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc Natl Acad Sci USA 94: 7959–7964.
Price, JT, Bonovich, MT & Kohn, EC (1997). The biochemistry of cancer dissemination. Crit Rev Biochem Mol Biol 32: 175–253.
Recklies, AD, Tiltman, KJ, Stoker, TA & Poole, AR (1980). Secretion of proteinases from malignant and nonmalignant human breast tissue. Cancer Res 40: 550–556.
Refsum, SB & Berdal, P (1967). Cell loss in malignant tumours in man. Eur J Cancer 3: 235–236.
Savill, J, Fadok, V, Henson, P & Haslett, C (1993). Phagocyte recognition of cells undergoing apoptosis. Immunol Today 14: 131–136.
Sinn, H, Schrenk, HH, Friedrich, EA, Schilling, U & Maier Borst, W (1990). Design of compounds having an enhanced tumour uptake, using serum albumin as a carrier. Part I. Int J Rad Appl Instrum B 17: 819–827.
Soreide, JA, Lea, OA & Kvinnsland, S (1991a). Cytosol albumin content in operable breast cancer. Correlations to steroid hormone receptors, other prognostic factors and prognosis. Acta Oncol 30: 797–802.
Soreide, JA, Lea, OA & Kvinnsland, S (1991b). Cytosol protein content and prognosis in operable breast cancer. Correlations with steroid hormone receptors and other prognostic factors. Breast Cancer Res Treat 20: 25–32.
Stehle, G, Sinn, H, Wunder, A, Schrenk, HH, Stewart, JCM, Hartung, G, Maier-Borst, W & Heene, DL (1997). Plasma protein (albumin) catabolism by the tumour itself-implications for tumor metabolism and the genesis of cachexia. Crit Rev Oncol Hematol 26: 77–100.
Stetler Stevenson, WG, Hewitt, R & Corcoran, M (1996). Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Semin Cancer Biol 7: 147–154.
Vercelli Retta, J, Manana, G, Almeida, E, Chiribao, C, Estevez, A & Moro, R (1987). Normal serum proteins in female breast carcinomas and fibroadenomas. An immunohistochemical study. Ann Pathol 7: 209–215.
Westley, BR & May, FEB (1999). Prognostic value of cathepsin D in breast cancer. Br J Cancer 79: 189–190.
Wunder, A, Stehle, G, Sinn, H, Schrenk, HH, Hoff-Biederbeck, D, Bader, F, Friedrich, EA, Peschke, P, Maier-Borst, W & Heene, DL (1997). Enhanced albumin uptake by rat tumors. Int J Oncol 11: 497–507.
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Mammographic compression: a force to be reckoned with. Br J Cancer 81, 1426–1428 (1999). https://doi.org/10.1038/sj.bjc.6690863
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690863
This article is cited by
-
No evidence for shedding of circulating tumor cells to the peripheral venous blood as a result of mammographic breast compression
Breast Cancer Research and Treatment (2013)